Hightower 6M Holding’s Amgen AMGN Stock Holding History

Hightower 6M Holding’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$1.85M	Buy	8,201 +7,267	+778%	+$1.76M	0.17%	76
2022 Q2	$227K	Sell	934 -1	-0.1%	-$245	0.02%	235
2022 Q1	$226K	Buy	+935	New	+$215K	0.02%	258

Other funds holding AMGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Hightower 6M Holding's AMGN Position: Q3 2022 in Review

Hightower 6M Holding increased its Amgen (AMGN) stake by 778% in Q3 2022, buying an estimated $1.76M and bringing the position to 8,201 shares worth $1.85M. The position accounts for 0.17% of the portfolio, ranked #76.

Hightower 6M Holding first reported a position in AMGN in Q1 2022 and has held it in 3 quarters since. 2,323 funds tracked by Wall St. Rank hold AMGN as of Q3 2022.

Hightower 6M Holding held 8,201 shares of Amgen worth $1.85M as of Q3 2022.
Hightower 6M Holding bought 7,267 Amgen shares in Q3 2022, an estimated $1.76M.
Amgen made up 0.17% of Hightower 6M Holding's portfolio in Q3 2022, its #76 holding.
Hightower 6M Holding first reported a position in Amgen in Q1 2022 and has held it in 3 quarters since.
2,323 funds tracked by Wall St. Rank held Amgen as of Q3 2022.

Based on Hightower 6M Holding's 13F filing for Q3 2022, filed 25 Oct 2022.